Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence

Gut

Volumn 67, Issue 10, 2018, Pages

  Lamas, Bruno ^a,b,c,d,e   Michel, Marie Laure ^e   Waldschmitt, Nadine ^b,f   Pham, Hang Phuong ^g   Zacharioudaki, Vassiliki ^b,f   Dupraz, Louise ^e   Delacre, Myriam ^b,f   Natividad, Jane M ^e   Da Costa, Gregory ^e   Planchais, Julien ^e   Sovran, Bruno ^e   Bridonneau, Chantal ^e   Six, Adrien ^a   Langella, Philippe ^e   Richard, Mathias L ^e   Chamaillard, Mathias ^b,f   Sokol, Harry ^a,b,c,d,e,h  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

^g ILTOO Pharma   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 22; LIPOCALIN; MONOSACCHARIDE; POLYSACCHARIDE; CARD9 PROTEIN, MOUSE; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CARD9 GENE; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; DIET; DISEASE SEVERITY; GENE; GENE SEQUENCE; GERMFREE MOUSE; HISTOLOGY; HUMORAL IMMUNITY; INFECTION SENSITIVITY; INFLAMMATION; MICROBIAL DIVERSITY; MICROFLORA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECIES COMPOSITION; WILD TYPE MOUSE; ADAPTIVE IMMUNITY; ANIMAL; DIET THERAPY; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; PROCEDURES; VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; CITROBACTER RODENTIUM; COLITIS; DIET THERAPY; GASTROINTESTINAL MICROBIOME; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; MICE; POLYSACCHARIDES; VIRULENCE;

EID: 85049516280     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-314195     Document Type: Article

References (30)

1. van Nood E, Vrieze A, Nieuwdorp M, etal. Duodenal infusion of donor feces for recurrent Clostridium difficile. N EnglJ Med 2013;368:407-15.
2. Guo X, Liang Y, Zhang Y, et al. Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity 2015;42:731-43.
3. Kamada N, Chen GY, Inohara N, etal. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013;14:685-90.
4. Collins JW, Keeney KM, Crepin VF,etal. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol 2014;12:612-23.
5. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2:123-40.
6. Mundy R, MacDonald TT, Dougan G, etal. Citrobacter rodentium of mice and man. Cell Microbiol 2005;7:1697-706.
7. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-24.
8. Sokol H, Conway KL, Zhang M, etal. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 2013; 145:591-601.
9. Lamas B, Richard ML, Leducq V,etal. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor liqands. Nat Med 2016;22:598-605.
10. Kamada N, Sakamoto K, Seo SU, S-uu S, etal. Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination. Cell Host Microbe 2015; 17:617-27.
11. Mellies JL, Elliott SJ, Sperandio V, et al. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 1999;33:296-306.
12. Kamada N, Kim YG, Sham HP, etal. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012;336:1325-9.
13. Wiles S, Pickard KM, Peng K, etal. In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun 2006;74:5391-6.
14. Segata N, Izard J, Waldron I, etal. Metagenomic biomarker discoveiy and explanation. Genome Biol 2011;12:R60.
15. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13:R79.
16. El Kaoutari A, Armougom F, Raoult D, etal. Gut microbiota and digestion of polysaccharides. Med Sci: M/S 2014;30:259-65.
17. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003;62:67-72.
18. Kim M, Qie Y, Park J, etal. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 2016;20:202-14.
19. Ghosh S, Dai C, Brown K, etal. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am 1 Physiol Gastrointest Liver Physiol 2011;301:G39-G49.
20. Bry L, Brigl M, Brenner MB. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. InfectImmun 2006;74:673-81.
21. Maaser C, Housley MP, limura M, etal. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 2004;72:3315-24.
22. Pickert G, Neufert C, Leppkes M, etal. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009;206:1465-72.
23. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th 17 cytokine. Immunol Rev 2013;252:1 16-32.
24. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011;12:383-90.
25. Stelter C, Kappeli R, Konig C,etal. Salmonella-induced mucosal lectin Reglllβ kills competing gut microbiota. PLoS One 2011;6:e20749.
26. Ishigame El, Kakuta S, Nagai T, etal. Differential roles of interleukin- 17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009;30:108-19.
27. Zheng Y, Valdez PA, Danilenko D M .et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14:282-9.
28. Willing BP, Vacharaksa A, Croxen M, et al. Altering host resistance to infections through microbial transplantation. PLoS One 2011;6:e26988.
29. Ivanov II, Atarashi K, Manel N, etal. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485-98.
30. Elara El, Ishihara C, Takeuchi A, et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat Immunol 2007;8:619-29.